Barlow Carrolee
SEC insider (Form 3/4/5 filer). CIK 0001745316. Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 24, 2026. Located in ROCKVILLE, MD.
Companies Barlow Carrolee has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director
Barlow Carrolee
CIK: 0001745316
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect4.5K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
4.5K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
3K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
5K shares- - Feb 22, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Units
5.4K shares- - Feb 22, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect5.4K shares- - Feb 19, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
7.3K shares- - Feb 19, 2025SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
4.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 4,475 | - | $0 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 4,475 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 2,989 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Feb 22, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Units | 5,369 | - | - | Direct |
| Feb 22, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 5,369 | - | - | Direct |
| Feb 19, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 7,296 | - | - | Direct |
| Feb 19, 2025 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 4,475 | - | - | Direct |
1-8 of 8 transactions